US Stock MarketDetailed Quotes

DMAC DiaMedica Therapeutics

Watchlist

6.470
+0.220+3.52%

Trading Feb 27 13:46 ET

276.66MMarket Cap-11.55P/E (TTM)

DiaMedica Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

DiaMedica Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
Nov 13, 2024	2024/Q3	0.000 / 0.000	--
Aug 7, 2024	2024/Q2	0.000 / 0.000	--
May 8, 2024	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

Nov 13, 20242024/Q30.000 / 0.000--

Aug 7, 20242024/Q20.000 / 0.000--

May 8, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

DiaMedica Therapeutics Earnings Reports

DiaMedica Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 16:29 ET

DiaMedica Therapeutics | 8-K: DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results

Nov 13, 2024 16:26 ET

DiaMedica Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 7, 2024 16:37 ET

DiaMedica Therapeutics | 8-K: DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2024 Financial Results